Here's what you need to know about TAVR (transcatheter aortic valve replacement), a five-year-old procedure that's changing patient outcomes.
Jane Racey Gleeson
Jane Racey Gleeson has been a member of the University of Michigan Frankel Cardiovascular Center’s communications team as a contributing writer for the past three years. She works with the team to produce targeted communications that meet the Frankel CVC’s goals. Gleeson’s 30 years in the technical communications field extend to custom publications, website development and integrated marketing for a variety of clients. She received her bachelor’s degree with honors in journalism from Oakland University in Rochester, Michigan.
Five years ago, aortic stenosis patients had very few options. Today, TAVR technology has changed all that. Here is one 82-year-old’s story.
If information about your anticoagulant has your head spinning, your health care provider and a new anticoagulant patient toolkit can help.
These two incidents can be confused if you don’t know what to look for. Here’s what to know — and when to get help.